Cell And Gene Articles, App Notes, Case Studies, & White Papers
-
A Scalable Platform To Revolutionize Gene Therapy Manufacturing
11/22/2024
Discover how our innovative rAAV production platform can revolutionize your gene therapy pipeline with unparalleled yield, quality, and scalability.
-
Real-Life Application Of Intensified Chromatography – See The Results
4/5/2024
Explore the impact and benefits of multi-column chromatography, taking into consideration product quality consistency as well as the potential cost and resin savings compared to batch chromatography.
-
CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry
4/23/2025
Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.
-
Driving Early-Phase Success In Advanced Solid Tumors Study
3/24/2025
A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.
-
How To Evaluate And Compare Real-Time PCR Reactions
10/30/2024
Learn about the key factors that influence qPCR reaction performance and provides guidelines for evaluating and comparing reactions run under varying conditions to ensure reliable data interpretation.
-
Bringing Clinical Trials To Everyone's Backyard
1/10/2025
Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.
-
Oesophageal Cancer: Global Clinical Trial Landscape (2024)
8/19/2024
Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.
-
Streamlining Phase I/II Oncology Trials: A Global CRO Partnership
3/17/2025
Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
1/15/2025
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
Optimizing Time And Cost Efficiency In Cell Line Development
10/28/2024
Discover a system that automates mAb purification, reducing time and costs in cell line development while improving reproducibility, with faster processing than traditional methods.